A 67-year-old man presented to our hospital with massive mitral and aortic valve prosthetic endocarditis 2 months after transcatheter percutaneous closure of a mitral paravalvular leak with an Amplatzer duct occluder device (AGA Medical Corp, Plymouth MN). He underwent successful reoperation for valve prosthesis replacement and reconstruction of the anterior fibrous trigone. Although transcatheter treatment of periprosthetic valve defects has been shown to be feasible, follow-up data are still limited. This procedure should be reserved only for patients who are not eligible for open surgical procedures and those with small periprosthetic defects. © 2013 The Society of Thoracic Surgeons.
Mitral and aortic valve prosthetic endocarditis after percutaneous closure of mitral paravalvular leak / Malvindi, P. G.; Raffa, G. M.; Cappai, A.; Barbone, A.; Basciu, A.; Settepani, F.; Citterio, E.; Ornaghi, D.; Tarelli, G.; Vitali, E.. - In: ANNALS OF THORACIC SURGERY. - ISSN 0003-4975. - 95:2(2013), pp. e45-e46. [10.1016/j.athoracsur.2012.08.020]
Mitral and aortic valve prosthetic endocarditis after percutaneous closure of mitral paravalvular leak
Malvindi P. G.;
2013-01-01
Abstract
A 67-year-old man presented to our hospital with massive mitral and aortic valve prosthetic endocarditis 2 months after transcatheter percutaneous closure of a mitral paravalvular leak with an Amplatzer duct occluder device (AGA Medical Corp, Plymouth MN). He underwent successful reoperation for valve prosthesis replacement and reconstruction of the anterior fibrous trigone. Although transcatheter treatment of periprosthetic valve defects has been shown to be feasible, follow-up data are still limited. This procedure should be reserved only for patients who are not eligible for open surgical procedures and those with small periprosthetic defects. © 2013 The Society of Thoracic Surgeons.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
